Showing results (181-190 of 322) with videos related to

Sort By:
Pageof 33
American Journal of Hematology|March 26, 2022
Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosisFrancesco Mannelli, Sara Bencini, Giacomo Coltro, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 10, 2025
Orthopaedic Surgery Outcomes in Patients With Haemophilia A or B Treated With Extended Half-Life Recombinant Factor VIII and IX Fc Fusion Proteins: A Multicentre Prospective StudyLuigi Piero Solimeno, Roberta Gualtierotti, Emanuele Guido, et al.
American Journal of Hematology|September 4, 2023
A globally applicable "triple A" risk model for essential thrombocythemia based on Age, Absolute neutrophil count, and Absolute lymphocyte countAyalew Tefferi, Giuseppe G Loscocco, Faiqa Farrukh, et al.
Haematologica|December 22, 2010
Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3Tiziano Barbui, Alessandra Carobbio, Guido Finazzi, et al.
American Journal of Hematology|November 23, 2017
Driver mutations and prognosis in primary myelofibrosis: Mayo-Careggi MPN alliance study of 1,095 patientsAyalew Tefferi, Maura Nicolosi, Mythri Mudireddy, et al.
Blood Advances|November 11, 2018
Mayo alliance prognostic system for mastocytosis: clinical and hybrid clinical-molecular modelsAnimesh Pardanani, Sahrish Shah, Francesco Mannelli, et al.
The New England Journal of Medicine|March 2, 2012
JAK inhibition with ruxolitinib versus best available therapy for myelofibrosisClaire Harrison, Jean-Jacques Kiladjian, Haifa Kathrin Al-Ali, et al.
British Journal of Haematology|June 22, 2010
A pilot study of the Histone-Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasmsAlessandro Rambaldi, Chiara Maria Dellacasa, Guido Finazzi, et al.
British Journal of Haematology|December 13, 2006
The haematocrit and platelet target in polycythemia veraMarcello Di Nisio, Tiziano Barbui, Leonardo Di Gennaro, et al.
Blood|July 11, 2013
Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus reportAyalew Tefferi, Francisco Cervantes, Ruben Mesa, et al.
Pageof 33